Pulmonary Embolism
Conditions
Keywords
Pulmonary Embolism, Multidetector Computed Tomography, Radiation Dosage, Contrast Media, Individualized Medicine
Brief summary
Computed tomographic pulmonary angiography (CTPA) is considered the gold standard for the diagnosis of pulmonary embolism (PE). PE is a potentially fatal disease in which a thrombus is lodged into a pulmonary artery blocking blood flow and potentially leading to respiratory distress, acute right cardiac failure or death. Therefore early and correct diagnosis is crucial. The diagnostic and clinical value of CTPA has already been firmly substantiated. Unfortunately up to 7.3% of PE scans are still deemed to be non-diagnostic, for example due to insufficient contrast enhancement in the target arteries. Therefore future research should focus on two important aspects of CT imaging. On the one hand optimal enhancement for the individual patient, on the other hand preventing additional risk of CT imaging - namely contrast induced nephropathy (CIN) and radiation risk. Thus the purpose of our study will be to optimize radiation dose settings (e.g. tube voltage, tube current) and CM application for the individual patient in CTPA.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Suspicion of pulmonary embolism
Exclusion criteria
* Severe allergy against Iopromide or any of the ingredients, previous severe CM reaction (according to current ESUR guidelines), renal insufficiency, pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Image quality | one year | Evaluation of subjective and objective image quality based on individualized CTPA protocols |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Reduction of radiation dose | one year | Effect of individualized tube voltage settings on radiation |
Countries
Netherlands